Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 1858
  • Home
  • Print this page
  • Email this page

    Article Cited by others


AZD9291-induced Acute Interstitial Lung Disease

Nie Ke-Ke, Zou Xiao, Geng Chuan-Xin, Zhang Ling, Liu Shi-Chao, Zhang Chun-Ling, Ji You-Xin

Year : 2016| Volume: 129| Issue : 12 | Page no: 1507-1508

   This article has been cited by
1 A Case of EGFR-mutant Non-Small Cell Lung Cancer Accompanied by Transient Asymptomatic Pulmonary Opacities Successfully Treated with "Stop-And-Go" Osimertinib
Keigo Kobayashi,Katsuhiko Naoki,Aoi Kuroda,Hiroyuki Yasuda,Ichiro Kawada,Kenzo Soejima,Tomoko Betsuyaku
Internal Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
Hansang Lee,Ho Yun Lee,Jong-Mu Sun,Se-Hoon Lee,Youjin Kim,Song Ee Park,Jin Seok Ahn,Keunchil Park,Myung-Ju Ahn
Journal of Thoracic Oncology. 2018; 13(8): 1106
[Pubmed]  [Google Scholar] [DOI]
3 Transient Asymptomatic Pulmonary Opacities Occurring during Osimertinib Treatment
Sinead A. Noonan,Peter B. Sachs,D. Ross Camidge
Journal of Thoracic Oncology. 2016; 11(12): 2253
[Pubmed]  [Google Scholar] [DOI]
4 Osimertinib
Reactions Weekly. 2016; 1608(1): 215
[Pubmed]  [Google Scholar] [DOI]


Read this article